KALV - Kalvista Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KALV (1348911)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
6 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S1-8-14-31-78

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-10-12
KALVRa Capital Management, LLCDir, 10%P - Purchase$8.50+850,0001,441,070+144%+$7,225,000
2017-10-12
KALVShah Rajeev M.Dir, 10%P - Purchase$8.50+850,0001,441,070+144%+$7,225,000
M
2017-10-10
KALVNovo Holdings A/s10%S - Sale$9.64-2,725,2830-100%-$26,271,182
AM
2017-09-13
KALVNovo Holdings A/s10%S - Sale$7.21-176,6442,725,283-6%-$1,273,956
M
2017-09-13
KALVNovo Holdings A/s10%S - Sale$7.21-176,6472,725,280-6%-$1,273,980
D
2015-12-30
CBYLRenzi DavidPres, CEOS - Sale+OE$3.70-10,0000-100%-$37,000-8-14-31-78

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top